Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 22 October 2012 | By Alexander Gaffney, RAC,
The European Medicines Agency (EMA) has appointed Ian Hudson as the new vice-chair of its Committee for Medicinal Products for Human Use (CHMP) after its previous vice-chair was appointed to the position of chair of the CHMP.
Hudson (PDF) has been a member of the CHMP since 2004, and has also served on the Paediatric Committee (PDCO), the Committee for Proprietary Medicinal Products (CPMP) and the guideline consistency group. Outside of EMA's advisory groups, he currently serves as the director of the UK's Medicines and Healthcare products Regulatory Agency's (MHRA) Licensing Division.
In a form (PDF) made available through EMA, Hudson declared no conflicts of interest.
Before joining MHRA's predecessor agency in 2001, Hudson practiced as a pediatrician, a research fellow at the University of Glasgow and a researcher at SmithKline Beecham.
CHMP's transitions were prompted in April by the abrupt resignation of Eric Abadie, the longtime chair of the committee, after he became embroiled in a safety scandal involving regulatory oversight of the French diabetes drug Mediator. The use of Mediator in France has been linked to hundreds of deaths, and is particularly controversial because the drug had been banned in nearly every other country in the EU for its known safety risks.
Abadie had served as a paid scientific advisor to French regulators, and after resigning from his position with AFSSAPS was unable to obtain remuneration for his service to CHMP, which is an unpaid position, and resigned.
The previous vice-chair of the committee, Thomas Salmonson, was appointed to the position of chair of the CHMP in September. The position had been filled on a temporary basis by Salmonson since April 2012, when Abadie resigned.
Tags: Hudson, Salmonson, Abadie, Latest News, CHMP
Regulatory Focus newsletters
All the biggest regulatory news and happenings.